Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Vekemans

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2019
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product CharacteristicsJohan Vekemans, Fernando Gouvea-Reis, Jerome H Kim, et al.
The Lancet. Infectious Diseases|June 29, 2019
New hope for tuberculosis vaccinesOle F Olesen, Fareed Abdullah, Rene Coppens, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
Plos One|July 13, 2011
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasitesPhilip Bejon, Louise Turner, Thomas Lavstsen, et al.
Vaccine|February 6, 2018
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Martin Friede, et al.
The Lancet. Microbe|June 17, 2023
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Kristin N Nelson, Gavin Churchyard, Frank Cobelens, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
Malaria Journal|August 6, 2011
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccineChristine Swysen, Johan Vekemans, Myriam Bruls, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccineAmir Horowitz, Julius C R Hafalla, Elizabeth King, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2019
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product CharacteristicsJohan Vekemans, Fernando Gouvea-Reis, Jerome H Kim, et al.
The Lancet. Infectious Diseases|June 29, 2019
New hope for tuberculosis vaccinesOle F Olesen, Fareed Abdullah, Rene Coppens, et al.
The Lancet. Respiratory Medicine|January 25, 2024
What is next for BCG revaccination to prevent tuberculosis?Richard G White, Andrew J Fiore-Gartland, Willem A Hanekom, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
Plos One|July 13, 2011
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasitesPhilip Bejon, Louise Turner, Thomas Lavstsen, et al.
Vaccine|February 6, 2018
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristicsJohan Vekemans, Vasee Moorthy, Martin Friede, et al.
The Lancet. Microbe|June 17, 2023
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Kristin N Nelson, Gavin Churchyard, Frank Cobelens, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
Malaria Journal|August 6, 2011
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccineChristine Swysen, Johan Vekemans, Myriam Bruls, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccineAmir Horowitz, Julius C R Hafalla, Elizabeth King, et al.
Pageof 12